These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18448977)

  • 1. The function and biological role of toll-like receptors in infectious diseases: an update.
    Hornef MW; Henriques-Normark B; Normark S
    Curr Opin Infect Dis; 2008 Jun; 21(3):304-12. PubMed ID: 18448977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling adaptors used by Toll-like receptors: an update.
    Kenny EF; O'Neill LA
    Cytokine; 2008 Sep; 43(3):342-9. PubMed ID: 18706831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs.
    Jo EK
    Curr Opin Infect Dis; 2008 Jun; 21(3):279-86. PubMed ID: 18448973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toll-like receptor in lung response to pathogens].
    Rivas-Santiago B; Juárez E
    Rev Invest Clin; 2007; 59(6):481-8. PubMed ID: 18402340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular NOD-like receptors in innate immunity, infection and disease.
    Franchi L; Park JH; Shaw MH; Marina-Garcia N; Chen G; Kim YG; Núñez G
    Cell Microbiol; 2008 Jan; 10(1):1-8. PubMed ID: 17944960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors.
    Romagne F
    Drug Discov Today; 2007 Jan; 12(1-2):80-7. PubMed ID: 17198976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors and adaptor molecules in liver disease: update.
    Seki E; Brenner DA
    Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of endogenous triggers on trauma-associated inflammation.
    Zedler S; Faist E
    Curr Opin Crit Care; 2006 Dec; 12(6):595-601. PubMed ID: 17077693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections.
    Turvey SE; Hawn TR
    Clin Immunol; 2006 Jul; 120(1):1-9. PubMed ID: 16563867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of Toll-like receptors in regulation of immune responses in norm and pathology].
    Spivak NIa; Bogdanova IM; Martirosova NI; Malaĭtsev VV
    Fiziol Zh (1994); 2008; 54(6):87-99. PubMed ID: 19227245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The innate immune system and its relevance to neonatal sepsis.
    Kenzel S; Henneke P
    Curr Opin Infect Dis; 2006 Jun; 19(3):264-70. PubMed ID: 16645488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forward genetic analysis of TLR-signaling pathways: an evaluation.
    Hoebe K; Beutler B
    Adv Drug Deliv Rev; 2008 Apr; 60(7):824-9. PubMed ID: 18331766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of TLR activation in inflammation.
    Sabroe I; Parker LC; Dower SK; Whyte MK
    J Pathol; 2008 Jan; 214(2):126-35. PubMed ID: 18161748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts.
    Chignard M; Balloy V; Sallenave JM; Si-Tahar M
    Clin Immunol; 2007 Sep; 124(3):238-43. PubMed ID: 17604224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in Toll-like receptor genes and risk of cancer.
    El-Omar EM; Ng MT; Hold GL
    Oncogene; 2008 Jan; 27(2):244-52. PubMed ID: 18176606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of TLR expression, a new perspective for the role of VIP in immunity.
    Gomariz RP; Arranz A; Juarranz Y; Gutierrez-Cañas I; Garcia-Gomez M; Leceta J; Martínez C
    Peptides; 2007 Sep; 28(9):1825-32. PubMed ID: 17706836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts of molecular defence mechanisms operative during urinary tract infection.
    Weichhart T; Haidinger M; Hörl WH; Säemann MD
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexities of targeting innate immunity to treat infection.
    Brown KL; Cosseau C; Gardy JL; Hancock RE
    Trends Immunol; 2007 Jun; 28(6):260-6. PubMed ID: 17468048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.